Table 1 Clinical characteristics and prognosis of hematologic malignancies and non - hematologic malignancies
Non- hematologic malignancies (n = 17) | Hematologic malignancies (n = 14) | p-value | |||
|---|---|---|---|---|---|
sex (male/female) | 8/9 | 8/6 | |||
symptoms | seizure | 16 (94.1%) | 13 (92.9%) | 1.000 | |
headache | 11 (64.7%) | 8 (57.1%) | 0.724 | ||
visual impairments | blurred vision | 8 (47.1%) | 7 (50%) | 1.000 | |
blind | 2 (11.8%) | 0 | 0.488 | ||
cortical blindness | 1 (5.9%) | 2 (14.3%) | 0.576 | ||
confusion | 9 (53.0%) | 4 (28.6%) | 0.275 | ||
High blood pressure | 12 (70.6%) | 7 (50%) | 0.288 | ||
Abnormal brain imaging | Occipital lobe | 13 (76.5%) | 11 (78.6%) | 1.000 | |
Parietal lobe | 13 (76.5%) | 10 (71.4%) | 1.000 | ||
Frontal lobe | 7 (41.2%) | 6 (42.9%) | 1.000 | ||
prognosis | Complete remission | 16 (94.1%) | 9 (64.3%) | 0.101 | |
Partial remission | 0 | 3 (21.4%) | |||
death | 1 (5.9%) | 2 (14.3%) | |||